In vitro activity of human defensins HNP-1 and hBD-3 against multidrug-resistant ESKAPE Gram-negatives of clinical origin and selected peptidoglycan recycling-defective mutants
In vitro dynamics and mechanisms of cefiderocol resistance development in wild-type, mutator and XDR Pseudomonas aeruginosa
Eurobiofilms 2022: A translational perspective of biofilm-related persistent infections.
Gut microbiome and plasma lipidome analysis reveals a specific impact of Clostridioides difficile infection on intestinal bacterial communities and sterol metabolism.
The effects of single and multiple resistance mechanisms on bacterial response to meropenem.
Impact of chromosomally encoded resistance mechanisms and transferable β-lactamases on the activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa.
Impact of multidrug resistance on the virulence and fitness of Pseudomonas aeruginosa: a microbiological and clinical perspective.
Differential contribution of PBP occupancy and efflux on the effectiveness of β-lactams at their target site in clinical isolates of Neisseria gonorrhoeae.
Genomic virulence markers are associated with severe outcomes in patients with Pseudomonas aeruginosa bloodstream infection.
Whole-genome sequence-guided PCR for the rapid identification of the Pseudomonas aeruginosa ST175 high-risk clone directly from clinical samples
Whole Genome Sequencing Evidences High Rates of Relapse in Clostridioides difficile Infection Caused by the Epidemic Ribotype 106
Visible-Light-Activated Molecular Machines Kill Fungi by Necrosis Following Mitochondrial Dysfunction and Calcium Overload.
Vaccines against monkeypox.
Transmitted drug resistance to antiretroviral drugs in Spain during the period 2019-2021.
To update or not to update the ESCMID guidelines for the diagnosis and treatment of biofilm infections – That is the question! The opinion of the ESGB board.
The new generation of messenger RNA (mRNA) vaccines against influenza.
The molecular epidemiology of SARS-CoV-2 in the Pityusic Islands shows multiple introductions and fast replacements of variants in a touristic worldwide hot spot.
The CARBA-MAP study: national mapping of carbapenemases in Spain (2014-2018).
The balance between antibiotic resistance and fitness/virulence in Pseudomonas aeruginosa: an update on basic knowledge and fundamental research.
Spanish Antibiogram Committee (COESANT) recommendations for cumulative antibiogram reports.
Simultaneous and divergent evolution of resistance to cephalosporin/β-lactamase inhibitor combinations and imipenem/relebactam following ceftazidime/avibactam treatment of MDR Pseudomonas aeruginosa infections.
Significant increase of CTX-M-15-ST131 and emergence of CTX-M-27-ST131 Escherichia coli high-risk clones causing healthcare-associated bacteraemia of urinary origin in Spain (ITUBRAS-2 project).
Recommendations of the Spanish Antibiogram Committee (COESANT) for in vitro susceptibility testing of antimicrobial agents by disk diffusion.
Rapid Phenotypic Convergence towards Collateral Sensitivity in Clinical Isolates of Pseudomonas aeruginosa Presenting Different Genomic Backgrounds.
Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis.
Pseudomonas aeruginosa and the Complement System: A Review of the Evasion Strategies.
Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients.
Phenotypic and Genotypic Antimicrobial Susceptibility Testing of Chlamydia trachomatis Isolates from Patients with Persistent or Clinical Treatment Failure in Spain.
Penicillin-Binding Protein Occupancy Dataset for 18 β-Lactams and 4 β-Lactamase Inhibitors in Neisseria gonorrhoeae
Penicillin-Binding Protein Occupancy Dataset for 18 β-Lactams and 4 β-Lactamase Inhibitors in Neisseria gonorrhoeae
Penicillin-Binding Protein 5/6 Acting as a Decoy Target in Pseudomonas aeruginosa Identified by Whole-Cell Receptor Binding and Quantitative Systems Pharmacology.
PBP Target Profiling by β-Lactam and β-Lactamase Inhibitors in Intact Pseudomonas aeruginosa: Effects of the Intrinsic and Acquired Resistance Determinants on the Periplasmic Drug Availability.
Outcomes of octogenarians and nonagenarians with Pseudomonas aeruginosa bacteremia: a multicenter retrospective study.
Mutation Analysis in Regulator DNA-Binding Regions for Antimicrobial Efflux Pumps in 17,000 Pseudomonas aeruginosa Genomes.
Molecular characterization of a suspected IMP-type carbapenemase-producing Pseudomonas aeruginosa outbreak reveals two simultaneous outbreaks in a tertiary-care hospital.
Mixed strain pathogen populations accelerate the evolution of antibiotic resistance in patients.
Mechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms.
La nueva generación de vacunas de ARN mensajero (ARNm) frente a la gripe
Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients.
In vitro evolution of cefepime/zidebactam (WCK 5222) resistance in Pseudomonas aeruginosa: dynamics, mechanisms, fitness trade-off and impact on in vivo efficacy
In vitro dynamics and mechanisms of cefiderocol resistance development in wild-type, mutator and XDR Pseudomonas aeruginosa.
Impact of adherence to individual quality-of-care indicators on the prognosis of bloodstream infection due to Staphylococcus aureus: a prospective observational multicentre cohort.
Hyperinflammatory Immune Response in COVID-19: Host Genetic Factors in Pyrin Inflammasome and Immunity to Virus in a Spanish Population from Majorca Island.
Genetic Characterization of Non-Lymphogranuloma venereum Chlamydia trachomatis Indicates Distinct Infection Transmission Networks in Spain.
Fever and migratory nodules in the lung.
Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the diagnosis and antimicrobial treatment of infections due to carbapenem-resistant Gram-negative bacteria.
Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the diagnosis and antimicrobial treatment of infections due to carbapenem-resistant Gram-negative bacteria.
Environmental surveillance of Pseudomonas aeruginosa in recreational waters in tourist facilities of the Balearic Islands, Spain (2016-2019).
Enhancing SARS-CoV-2 Surveillance through Regular Genomic Sequencing in Spain: The RELECOV Network.
Endocarditis caused by Neisseria bacilliformis: a case report and review of literature.
Elevated complement C3 and increased CD8 and type 1 helper lymphocyte T populations in patients with post-COVID-19 condition.
Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized trial.
Effective inhibition of PBPs by cefepime and zidebactam in the presence of VIM-1 drives potent bactericidal activity against MBL-expressing Pseudomonas aeruginosa
Diagnostic accuracy of Panbio™ rapid antigen test for SARS-CoV-2 in paediatric population.
Detection of co-infection by Herpes simplex virus type 1 and type 2 in female genital ulcers
CRISPR-Cas13a-Based Assay for Accurate Detection of OXA-48 and GES Carbapenemases.
Comparative Analysis of Peptidoglycans From Pseudomonas aeruginosa Isolates Recovered From Chronic and Acute Infections
Comparative analysis of in vitro dynamics and mechanisms of ceftolozane/tazobactam and imipenem/relebactam resistance development in Pseudomonas aeruginosa XDR high-risk clones
Ceftolozane/tazobactam plus tobramycin against free-floating and biofilm bacteria of hypermutable Pseudomonas aeruginosa epidemic strains: Resistance mechanisms and synergistic activity.
Ceftolozane-Tazobactam against Pseudomonas aeruginosa Cystic Fibrosis Clinical Isolates in the Hollow-Fiber Infection Model: Challenges Imposed by Hypermutability and Heteroresistance.
Cefiderocol resistance genomics in sequential chronic Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Biochemical Insights into Imipenem Collateral Susceptibility Driven by ampC Mutations Conferring Ceftolozane/Tazobactam Resistance in Pseudomonas aeruginosa.
Bacterial virulence regulation through soluble peptidoglycan fragments sensing and response: knowledge gaps and therapeutic potential.
Are GES carbapenemases underdiagnosed? An allelic discrimination assay for their accurate detection and differentiation
Antimicrobial stewardship in hospitals: Expert recommendation guidance document for activities in specific populations, syndromes and other aspects (PROA-2) from SEIMC, SEFH, SEMPSPGS, SEMICYUC and SEIP.
An increase in erythromycin resistance in methicillin-susceptible Staphylococcus aureus from blood correlates with the use of macrolide/lincosamide/streptogramin antibiotics. EARS-Net Spain (2004-2020).
Activity of Imipenem-Relebactam against a Large Collection of Pseudomonas aeruginosa Clinical Isolates and Isogenic β-Lactam-Resistant Mutants
A paper biosensor for overcoming matrix effects interfering with the detection of sputum pyocyanin with competitive immunoassays.
A Genomic Snapshot of the SARS-CoV-2 Pandemic in the Balearic Islands
[EDP-938, a new antiviral with inhibitory activity against the nucleoprotein of the respiratory syncytial virus].
[Alternative viral diagnosis in suspected monkeypox].
[Changes in the incidence and clinical manifestations of paediatric respiratory infections of viral aetiology during the SARS-CoV-2 pandemic].
[Nirmatrelvir plus ritonavir (Paxlovid) a potent SARS-CoV-2 3CLpro protease inhibitor combination].
[Possible effect of the “original antigenic sin” in vaccination against new variants of SARS-CoV-2].
[The Victoria and Yamagata Lineages of Influenza B Viruses, unknown and undervalued].
Activity of cefiderocol, imipenem/relebactam, cefepime/taniborbactam and cefepime/zidebactam against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa.
Acute retinal necrosis caused by herpes simplex type 2.
ATP Bioluminescence Assay To Evaluate Antibiotic Combinations against Extensively Drug-Resistant (XDR) Pseudomonas aeruginosa.
CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3.
Carbapenem Combinations for Infections Caused by Carbapenemase-Producing Pseudomonas aeruginosa: Experimental In Vitro and In Vivo Analysis
Cardiac Arrest Following Unsuspected Self-Poisoning With Doxylamine
Changes in the incidence and clinical manifestations of paediatric respiratory infections of viral aetiology during the SARS-CoV-2 pandemic.
Comparative analysis of in vitro dynamics and mechanisms of ceftolozane/tazobactam and imipenem/relebactam resistance development in Pseudomonas aeruginosa XDR high-risk clones.
Comparison of Ceftolozane/Tazobactam Infusion Regimens in a Hollow-Fiber Infection Model against Extensively Drug-Resistant Pseudomonas aeruginosa Isolates.
Current Positioning against Severe Infections Due to Klebsiella pneumoniae in Hospitalized Adults.
Dissolvable Polymer Valves for Sweat Chrono-Sampling in Wearable Paper-Based Analytical Devices.
Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective Study.
Effects of Inhaled Corticosteroids on the Innate Immunological Response to Pseudomonas aeruginosa Infection in Patients with COPD.
Fluconazole-resistant Candida parapsilosis clonally related genotypes: first report proving the presence of endemic isolates harbouring the Y132F ERG11 gene substitution in Spain.
Fluidoterapia en la sepsis y el shock séptico
Gut to lung translocation and antibiotic mediated selection shape the dynamics of Pseudomonas aeruginosa in an ICU patient
Hemithioindigo-Based Visible Light-Activated Molecular Machines Kill Bacteria by Oxidative Damage.
Imipenem-Relebactam Susceptibility in Enterobacterales Isolates Recovered from ICU Patients from Spain and Portugal (SUPERIOR and STEP Studies).
Impact of Aspergillus spp. isolation in the first 24 hours of admission in critically ill patients with severe influenza virus pneumonia.
Impact of Peptidoglycan Recycling Blockade and Expression of Horizontally Acquired β-Lactamases on Pseudomonas aeruginosa Virulence.
Improved cytometric analysis of untouched lung leukocytes by enzymatic liquefaction of sputum samples.
Improving the Quantification of Colorimetric Signals in Paper-Based Immunosensors with an Open-Source Reader
In vitro activity of imipenem/relebactam against Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal (SUPERIOR and STEP studies).
In vivo translational assessment of the GES genotype on the killing profile of ceftazidime, ceftazidime/avibactam and meropenem against Pseudomonas aeruginosa.
Increased mRNA Levels of ADAM17, IFITM3, and IFNE in Peripheral Blood Cells Are Present in Patients with Obesity and May Predict Severe COVID-19 Evolution.
Light-activated molecular machines are fast-acting broad-spectrum antibacterials that target the membrane.
Low Ciprofloxacin Concentrations Select Multidrug-Resistant Mutants Overproducing Efflux Pumps in Clinical Isolates of Pseudomonas aeruginosa.
Mammals’ humoral immune proteins and peptides targeting the bacterial envelope: from natural protection to therapeutic applications against multidrug-resistant Gram-negatives.
Micro- and nanosensors for detecting blood pathogens and biomarkers at different points of sepsis care.
Plasma-induced nanoparticle aggregation for stratifying COVID-19 patients according to disease severity.
Polymer Components for Paper‐Based Analytical Devices
Possible effect of the “original antigenic sin” in vaccination against new variants of SARS-CoV-2.
Possible effect of the “original antigenic sin” in vaccination against new variants of SARS-CoV-2
Prevalence of the fimbrial operon mrkABCD, mrkA expression, biofilm formation and effect of biocides on biofilm formation in carbapenemase-producing Klebsiella pneumoniae isolates belonging or not belonging to high-risk clones.
Rapid Identification and Classification of Pathogens That Produce Carbapenemases and Cephalosporinases with a Colorimetric Paper-Based Multisensor.
Recommendations for the management of critically ill patients with COVID-19 in Intensive Care Units.
Reinforcement of the Standard Therapy with Two Infusions of Convalescent Plasma for Patients with COVID-19: A Randomized Clinical Trial.
Role of Enzymatic Activity in the Biological Cost Associated with the Production of AmpC β-Lactamases in Pseudomonas aeruginosa.
Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial.
Selection of AmpC β-Lactamase Variants and Metallo-β-Lactamases Leading to Ceftolozane/Tazobactam and Ceftazidime/Avibactam Resistance during Treatment of MDR/XDR Pseudomonas aeruginosa Infections
Simulated Intravenous versus Inhaled Tobramycin with or without Intravenous Ceftazidime Evaluated against Hypermutable Pseudomonas aeruginosa via a Dynamic Biofilm Model and Mechanism-Based Modeling.
Spread of SARS-CoV-2 in hospital areas.
Staphylococcus aureus surface protein G (sasG) allelic variants: correlation between biofilm formation and their prevalence in methicillin-resistant S. aureus (MRSA) clones.
Suboptimal Concentrations of Ceftazidime/Avibactam (CAZ-AVI) May Select for CAZ-AVI Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa: In Vivo and In Vitro Evidence
Susceptibility profiles and resistance genomics of Pseudomonas aeruginosa isolates from European ICUs participating in the ASPIRE-ICU trial.
[Impact of hygienic and social distancing measures against SARS-CoV-2 on respiratory infections caused by other viruses].
[Impact of spike genetic variants in vaccines against SARS-CoV-2].
[Plitidepsin, an inhibitor of the cell elongation factor eEF1a, and molnupiravir an analogue of the ribonucleoside cytidine, two new chemical compounds with intense activity against SARS-CoV-2].
[Use of dried blood from the heel (Guthrie card) in the diagnosis of congenital enterovirus infection].
In Vivo Evolution of GES β-Lactamases Driven by Ceftazidime/Avibactam Treatment of Pseudomonas aeruginosa Infections
6-Halopyridylmethylidene Penicillin-Based Sulfones Efficiently Inactivate the Natural Resistance of Pseudomonas aeruginosa to β-Lactam Antibiotics.
A Genomic Snapshot of the SARS-CoV-2 Pandemic in the Balearic Islands.
A Large Multicenter Prospective Study of Community-Onset Healthcare Associated Bacteremic Urinary Tract Infections in the Era of Multidrug Resistance: Even Worse than Hospital Acquired Infections?
Activity of imipenem/relebactam against a Spanish nationwide collection of carbapenemase-producing Enterobacterales.
Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort study.
Correction to: The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients.
Detection of respiratory viruses in patients with suspected SARS-CoV-2 infection.
Distinct epidemiology and resistance mechanisms affecting ceftolozane/tazobactam in Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal depicted by WGS.
Emergence of Resistance to Novel Cephalosporin-β-Lactamase Inhibitor Combinations through the Modification of the Pseudomonas aeruginosa MexCD-OprJ Efflux Pump.
Evaluation of Rapid Polymyxin Pseudomonas test in clinical Pseudomonas aeruginosa isolates with various degrees of multidrug resistance.
Evolution, Clinical and Microbiological Characteristics of Invasive Pneumococcal Disease since the Introduction of the Pneumococcal Conjugate Vaccine 13-Valent in Adults over 18 Years Old.
Immunodetection of Lung IgG and IgM Antibodies against SARS-CoV-2 via Enzymatic Liquefaction of Respiratory Samples from COVID-19 Patients.
Impact of ceftolozane/tazobactam concentrations in continuous infusion against extensively drug-resistant Pseudomonas aeruginosa isolates in a hollow-fiber infection model.
In vitro evolution of cefepime/zidebactam (WCK 5222) resistance in Pseudomonas aeruginosa: dynamics, mechanisms, fitness trade-off and impact on in vivo efficacy.
Influenza vaccination in the time of SARS-CoV-2.
Inhaled corticosteroid dose is associated with Pseudomonas aeruginosa infection in severe COPD.
Metagenomics Analysis Reveals an Extraordinary Inner Bacterial Diversity in Anisakids (Nematoda: Anisakidae) L3 Larvae
Mobile origami immunosensors for the rapid detection of urinary tract infections.
Molecular Analysis of the Contribution of Alkaline Protease A and Elastase B to the Virulence of Pseudomonas aeruginosa Bloodstream Infections.
Molecular Basis of AmpC β-Lactamase Induction by Avibactam in Pseudomonas aeruginosa: PBP Occupancy, Live Cell Binding Dynamics and Impact on Resistant Clinical Isolates Harboring PDC-X Variants.
Molecular mechanisms driving the in vivo development of OXA-10-mediated resistance to ceftolozane/tazobactam and ceftazidime/avibactam during treatment of XDR Pseudomonas aeruginosa infections.
Multicenter Performance Evaluation of MALDI-TOF MS for Rapid Detection of Carbapenemase Activity in Enterobacterales: The Future of Networking Data Analysis With Online Software.
Neisseria gonorrhoeae antimicrobial resistance in Spain: a prospective multicentre study.
Norovirus outbreak causing gastroenteritis in a hotel in Menorca, Spain.
Panbio™ rapid antigen test for SARS-CoV-2 has acceptable accuracy in symptomatic patients in primary health care.
Pharmacodynamics of ceftazidime plus tobramycin combination dosage regimens against hypermutable Pseudomonas aeruginosa isolates at simulated epithelial lining fluid concentrations in a dynamic in vitro infection model.
Poor agreement between clinical screening and universal pre-procedure SARS-CoV-2 PCR testing prior to endoscopy.
Predicting Pseudomonas aeruginosa susceptibility phenotypes from whole genome sequence resistome analysis
Predictive Immunological, Virological, and Routine Laboratory Markers for Critical COVID-19 on Admission.
Procedimientos en Microbiología Clínica (número 71, 2.a edición 2021)
Pseudomonas aeruginosa Susceptibility in Spain: Antimicrobial Activity and Resistance Suppression Evaluation by PK/PD Analysis.
Pseudomonas aeruginosa: a clinical and genomics update.
Rapid evolution and host immunity drive the rise and fall of carbapenem resistance during an acute Pseudomonas aeruginosa infection.
Recommendations for antibiotic selection for severe nosocomial infections.
Spread of a SARS-CoV-2 variant through Europe in the summer of 2020.
Surveillance for Enteroviruses Associated with Hand, Foot, and Mouth Disease, and Other Mucocutaneous Symptoms in Spain, 2006-2020.
The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant.
Time-Kill Evaluation of Antibiotic Combinations Containing Ceftazidime-Avibactam against Extensively Drug-Resistant Pseudomonas aeruginosa and Their Potential Role against Ceftazidime-Avibactam-Resistant Isolates.
Validation of MALDI-TOF for the early detection of the ST175 high-risk clone of Pseudomonas aeruginosa in clinical isolates belonging to a Spanish nationwide multicenter study
Whole-genome sequence-guided PCR for the rapid identification of the Pseudomonas aeruginosa ST175 high-risk clone directly from clinical samples.
Conexión entre resistencia a quinolonas y fitness en Pseudomonas aeruginosa: impacto de las toxinas ExoU/ExoS en la modulación de mecanismos de resistencia y coste biológico
Organismo: Agencia Estatal de Investigación
Nacional
Subvención: 197.006 €
Ref.: CNS2023-144168
2024
De recursos inmunes inexplorados a hidrolasas bacterianas del peptidoglicano: un múltiple enfoque hacia nuevas estrategias antimicrobianas dirigidas a la pared celular
Organismo: FIS
Nacional
Subvención 117.370 euros
Ref.: PI21/00753
2022
Developing an Integrated approach to precision medicine targeting antimicrobial resistance of bacterial 'superbugs'
Organismo: National Health and Medical Research Council (NHMRC) Australian
Government
Internacional
Subvención: 51.763 euros
Ref.: APP1184428
2020
Enhanced Networking on Antimicrobial Resistance Surveillance with Next Generation Sequencing
Organismo: Unión Europea, Programa H2020-WIDESPREAD-2020-5
Internacional
Subvención: 150.362, 50 euros
Ref.: 9549
2020
Nuevas herramientas para optimizar el tratamiento de infecciones por N. gonorrhoeae MDR: Evaluación de dianas, Resistencia, Ultraestructura y Sinergia en Células Intactas (ICARUS-NG)
Organismo: Proyectos I+D+i 2020, retos tipo B MCIN
Nacional
Subvención: 159.720€ euros
Ref.: PID2020-112654RB-I00
2021
Dinamica, transformacion, y umbral del resistoma de Neisseria gonorrhoeae: desarrollo de nuevas herramientas moleculares para mejorar el diagnóstico, tratamiento y vigilancia (GonoRes)
Organismo: Proyectos I+D+i 2023, retos tipo B MCIN
Nacional
Subvención: 125.000€ euros
Ref.: PID2023-146055OB-I00
2024
HCV STAT: Eliminating hepatitis C on the Balearic Islands (Mallorca, Menorca and Ibiza): a study in governmental and non-governmental addiction service centres, a mobile methadone unit and a prison to test and link people who use drugs to HCV care
Organismo: Gilead
Internacional
2022
Caracterización de Neisseria meningitidis tras la introducción de la vacuna frente al serogrupo B e identificación de factores predisponentes del desarrollo de enfermedad meningocócica invasiva
Organismo: FIS
Nacional
Ref.: PI21/00132
2022
Mycoplasma genitalium infection: Prevalence of antimicrobial resistance in Spain and evaluation of a new treatment strategy
Organismo: FIS
Nacional
Ref.: PI21/01542
2022
Efectividad clínica y erradicación bacteriológica de 4 pautas antibióticas cortas en infecciones urinarias bajas en mujeres adultas [Estudio SCOUT]
Organismo: FIS
Nacional
Ref.: ICI20/00128
2021
Efectos del tratamiento con benzodiazepinas sobre la virulencia de Pseudomonas aeruginosa: ¿un potencial facilitador para la neumonía asociada a la ventilación mecánica?
Organismo: Projectes de recerca científica i tecnològica per al període 2020-2024,
Conselleria de Fons Europeus, Universitat i Cultura (Direcció General Política
Universitària i Recerca), Govern de les Illes Balears.
Regional
Subvención: 98.060 euros
Ref.: PDR2020/02
2021
Monitorización personalizada de la resistencia a los antibióticos a través de la determinación de la dinámica in vivo del resistoma de Pseudomonas aeruginosa
Organismo: FIS
Nacional
Subvención 176.660 euros
Ref.: PI21/00017
2022
Optimizing diagnosis, treatment and control of Pseudomonas aeruginosa infections through the monitoring of resistome dynamics at patient and at nation-wide levels
Organismo: FIS
Nacional
Subvención 197.375 euros
Ref.: PI24/00010
2025
Population analysis of Pseudomonas aeruginosa virulence
Organismo: NIH EEUU
Internacional
Subvención 300.000 USD
Ref.: NIH21/R01/SP0067824
2022
CIBER de Enfermedades Infecciosas
Organismo: ISCIII
Nacional
Subvención 60.000 euros/año
Ref.: CB21/00099
2022
Improving Surveillance of Antibiotic Resistant Pseudomonas aeruginosa in Europe
Organismo: JPMIAMR UE
Internacional
Subvención 50.000 euros
Ref.: ISARPAE
2023
Analysis of the role of corticoids in the modulation of biofilm formation by Pseudomonas aeruginosa in the COPD context
Organismo: European Society of Clinical Microbiology and Infectious Diseases
Internacional
Subvención: 20.000 €
Ref.: ESCMID_RG22
2022
Ensayo clínico aleatorizado, de superioridad, doble ciego, controlado con placebo, en fase II, para demostrar la eficacia del trasplante de microbiota fecal en la descolonización intestinal selectiva de los pacientes colonizados por enterobacterias productoras de carbapenemasas tipo KPC u OXA-48
Organismo: Fundación para la Investigación Biomédica de Córdoba (FIBICO).
Nacional
Ref.: KAPEDIS
2022
Problemática de la infección asociada a biofilms de P. aeruginosa XDR/DTR: evaluación de alternativas terapéuticas y de su impacto en la estructura del biofilm y el resistoma
Organismo: FIS
Nacional
Subvención 89.375,00 euros
Ref.: PI23/01086
2024
Evolución de la prevalencia y epidemiología de los genotipos de Chlamydia trachomatis causantes de linfogranuloma venéreo (LGV) en Baleares: aplicación en la optimización del diagnóstico microbiológico de las infecciones de transmisión sexual (ITS)
Organismo: Premios Proyecto Piloto 2024, Hospital Son Espases
Regional
Subvención: 5000€
2024
Validación de un modelo celular de interacción patógeno huésped basado en células IPSCS para el cribado de fármacos que bloquean está interacción
Agencia Financiadora: Proyectos de Excelencia 2022. Consejería de Universidad,
Investigación e Innovación Secretaría General de Investigación e Innovación, Junta de
Andalucía.
Regional
Cuantía: 175.869 euros
Ref.: ProyExcel_00116
2023
Desarrollo de herramientas para el control de la teniosis / cisticercosis en zonas endémicas y vigilancia de las helmintosis humanas emergentes en España
Organismo: Instituto de Salud Carlos III
Nacional
Cuantía: 80.000 euros
2023
La medicina de precisión contra la resistencia a antimicrobianos: Proyecto MePRAM
Organismo: Instituto de Salud Carlos III
Nacional
Cuantía: 4.339.500 euros
Ref.: PMP22/00092
2023
Estudio del mecanismo de acción de péptidos cíclicos (CP1 y CP3) como potenciales inhibidores de bombas de expulsión activa en Pseudomonas aeruginosa
Organismo: CIBERINFEC
Nacional
Cuantía: 60.000 euros
Ref.: IM22/INF/4
2022
Estudio de seroprevalencia de los virus Toscana y West Nile en Mallorca
Organismo Organismo: Premios Proyecto Piloto 2022, Hospital Son Espases
Regional
Cuantía: 5.000 euros
2022
REVERSE. pREVention and management tools for rEducing antibiotic Resistance in high prevalence Settings
Organismo: UE
Internacional
Dotación: 300.000 euros
Ref.: 965265
2021
Consolidation of WGS and RT-PCR activities for SARS-CoV-2 in Spain towards sustainable use and integration of enhanced infrastructure and processes in the RELECOV network
Organismo financiador: Comisión Europea
Internacional
Subvención: 50.307,51 euros
Ref.: 101113109
2023
Influencia de la apnea obstructiva del sueño y la carga hipóxica en biomarcadores de enfermedad de Alzheimer y en la microbiota orofaríngea e intestinal
Organismo: Instituto de Salud Carlos III.
Nacional
Subvención: 83.750 euros
2024
Primer catálogo de helmintos parásitos de la fauna silvestre Balear, ante los retos de la era OneHealth
Organismo: Govern de les Illes Balears (GOIB)
Regional
2023
Estudio multicéntrico para la mejora del diagnóstico y la caracterización molecular de las diferentes formas clínicas de leishmaniasis en el área Mediterránea
Organismo: Instituto de Salud Carlos III.
Nacional
2024
Pared celular, β-lactamasa AmpC, sistema inmune y virulencia: nuevas
conexiones y hallazgos en Pseudomonas aeruginosa
Tesis doctoral
Universitat de les Illes Balears, UIB
Doctorando: Gabriel Torrens
Directores: Antonio Oliver y Carlos Juan
Año: 2022
Novel treatment strategies for chronic respiratory infections based on the analysis of
antimicrobial resistance dynamics in Pseudomonas aeruginosa biofilms
Universitat de les Illes Balears, UIB
Doctoranda: Estrella Rojo Molinero.
Directores: Dr. Antonio Oliver Palomo y Dra. María Dolores Macià Romero
Microbiología Ambiental y Biomédica (UIB)
Año: 2021
Epidemiología molecular y mecanismos de resistencia en Pseudomonas aeruginosa:
Impacto de los clones de alto riesgo y análisis del resistoma a través de la
secuenciación masiva.
Universitat de les Illes Balears, UIB
Doctorando: Gabriel Cabot
Director: Dr. Antonio Oliver Palomo.
Año: 2021
Estudio de la interacción entre los marcadores de virulencia, los perfiles de resistencia y los clones de alto riesgo en Caenorhabditis elegans y Galleria mellonella. Evaluación del valor predictivo como marcadores pronósticos en la bacteriemia por Pseudomonas aeruginosa.
Universitat de les Illes Balears, UIB
Doctorando: Irina Sánchez
Director: Laura Zamorano y Antonio Oliver.
Año: 2021
Estrategias de Klebsiella pneumoniae para subvertir los sistemas defensivos del huésped
Universitat de le Illes Balears, UIB
Doctorando: María del Mar González Nicolau
Directores: Carlos Juan, David Moranta, Verónica Regueiro
Año: 2021
Efecto de los corticosteroides propionato de fluticasona y budesònida sobre la resistencia a los antibióticos de las biopelículas formadas por Pseudomonas aeruginosa
Trabajo fin de grado
Universitat de les Illes Balears, UIB
Año: 2024
Trabajo fin de grado
Universitat de les Illes Balears, UIB
Año: 2024
Revisión de técnicas y modelos experimentales para analizar la virulencia de Pseudomonas aeruginosa
Trabajo fin de grado
Universitat de les Illes Balears, UIB
Año: 2024
Dynamics and in vitro mechanisms of resistance development to first-line and experimental compounds in Neisseria gonorrhoeae
Trabajo fin de máster
Universitat de les Illes Balears, UIB
Año:2024
Mechanistic insights into synergistic combinations of non-antibiotic drugs and β lactams
Trabajo fin de máster
Universitat de les Illes Balears, UIB
Año: 2024
Caracterización extensiva de cepas de Pseudomonas aeruginosa de distintos orígenes
(ambientales, bacteriemia e infección pulmonar epoc) en respuesta al tratamiento con
corticosteroides
Trabajo fin de máster
Universitat de les Illes Balears, UIB
Año: 2023
Caracterización extensiva de cepas de Pseudomonas aeruginosa de distintos orígenes
(ambientales, bacteriemia e infección pulmonar epoc) en respuesta al tratamiento con
corticosteroides
Trabajo fin de master
Universitat de les Illes Balears, UIB
Año: 2023
Effect of Corticosteroids on Pseudomonas aeruginosa Quorum Sensing
Trabajo fin de máster
University of Nottingham
Año: 2023
Análisis de la actividad antimicrobiana de proteínas bacterianas purificadas con capacidad natural de degradar el peptidoglicano
Trabajo fin de grado
Universitat de les Illes Balears, UIB
Año: 2023
Epidemiología, diagnóstico y estudio de sensibilidad antibiótica en cepas de Helicobacter pylori procedentes de pacientes del servicio de salud de las Illes Balears
Trabajo fin de máster
Universitat de les Illes Balears, UIB
Año: 2023
Implicaciones de la microbiota intestinal en la patología humana
Trabajo fin de grado
Universitat de les Illes Balears, UIB
Año: 2023
Impact of the Type VI Secretion System and AmpDh3 amidase on Pseudomonas aeruginosa's capacity to compete with cystic fibrosis-related non-fermenting Gram-negative bacilli.
Trabajo fin de máster
Universitat de les Illes Balears, UIB
Año: 2022
ESTUDI DE L’ATENUACIÓ DE LA VIRULÈNCIA ASSOCIADA A L’EXPRESSIÓ DE β-LACTAMASES DE CLASSE C EN GRAM-NEGATIUS D’INTERÈS HOSPITALARI
Trabajo fin de grado
Universitat de les Illes Balears, UIB
Año: 2022
Eficacia del tratamiento con ceftolozano/tazobactam en las biopelículas de cepas XDR de Pseudomonas aeruginosa
Trabajo fin de máster
Universitat de les Illes Balears, UIB
Año: 2022
BLOQUEO DEL RECICLAJE DEL PEPTIDOGLICANO EN Pseudomonas aeruginosa: CONSTRUCCIÓN Y CARACTERIZACIÓN DE UN MUTANTE KNOCKOUT EN LA LIGASA Mpl
Trabajo fin de máster
Universitat de les Illes Balears, UIB
Año: 2021
Impacto del bloqueo del reciclaje del peptidoglicano y la expresión de beta-lactamasas de clase D sobre la capacidad de invasión celular de Pseudomonas aeruginosa.
Trabajo fin de máster
Universitat de les Illes Balears, UIB
Año: 2021
Mecanismos de resistencia a un nuevo antibiótico para el tratamiento de los biofilms
de Pseudomonas aeruginosa.Trabajo fin de máster
Universitat de les Illes Balears, UIB
Año: 2020
Premio Carlos Campillo 2024
Academia de ciencias médicas de Baleares
Premio mejor publicación científica HUSE 2023
Premio Fundación Soria Melguizo (IV edición) 2023 al Grupo de Resistencia antibiótica
IdISBa-Servicio de Microbiología HUSE. Dotación 50.000 EUR.
Premio a la mejor tesis doctoral: Gabriel Torrens, “Pared celular, β-lactamasa AmpC,
sistema inmune y virulencia: nuevas conexiones y hallazgos en Pseudomonas aeruginosa“,
bajo la dirección de Antonio Oliver y Carlos Juan. IX Jornadas Instituto de Investigación
Sanitaria de les Illes Balears (IdISBa), 29-30 noviembre 2022.
Premio al mejor póster IX Jornadas Instituto de Investigación Sanitaria de les Illes Balears (IdISBa), 29-30 noviembre 2022. “Impact of type 6 secretion system and AmpDh3 amidase on
Pseudomonas aeruginosa capacity to compete with cystic fibrosis-related non-fermenting
Gram-negatives”. María Escobar-Salom, Anna Rosaria Münch, Isabel María Barceló,
Elena Jordana-Lluch, Gabriel Torrens, Antonio Oliver, Carlos Juan.
Financiación ESTANCIAS CORTAS (máx. 3 meses) EN CENTROS DE INVESTIGACIÓN
NACIONALES, Comisión Investigación Hospital Son Espases. Centro receptor: Complejo
Hospitalario Universitario A Coruña-Instituto de Investigación Biomédica (INIBIC), Servicio
de Microbiología. Beneficiario: Isabel M. Barceló Munar. Investigador Responsable: Carlos
Juan
Premio a la mejor publicación científica del HUSE 2020. Categoría residentes
Del Barrio-Tofiño E.
Becas de investigación Hospital Universitario Son Espases: Estancias en Centros
Internacionales (Postdoc) University of Florida, FL, USA
Silvia Daiana López Argüello